• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Unspecified (PubMed=9246190).
  

PubMed=2418959
Russell P.J., Raghavan D., Gregory P., Philips J., Wills E.J., Jelbart M.E., Wass J., Zbroja R.A., Vincent P.C.
Bladder cancer xenografts: a model of tumor cell heterogeneity.
Cancer Res. 46:2035-2040(1986)

PubMed=3335421; DOI=10.1002/ijc.2910410115
Russell P.J., Jelbart M.E., Wills E.J., Singh S., Wass J., Wotherspoon J., Raghavan D.
Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation.
Int. J. Cancer 41:74-82(1988)

PubMed=2685375; DOI=10.1016/S0022-5347(17)39172-3
Walker K.Z., Russell P.J., Kingsley E.A., Philips J., Raghavan D.
Detection of malignant cells in voided urine from patients with bladder cancer, a novel monoclonal assay.
J. Urol. 142:1578-1583(1989)

PubMed=2328200; DOI=10.1038/bjc.1990.81; PMCID=PMC1971293
Brown J.L., Russell P.J., Philips J., Wotherspoon J., Raghavan D.
Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity.
Br. J. Cancer 61:369-376(1990)

PubMed=8635192; DOI=10.1007/BF01526554; PMCID=PMC11037576
Kingsley E.A., Carter T.E., Barrow K.D., Russell P.J.
Characterisation of the anti-bladder-cancer monoclonal antibody BLCA-8: identification of its antigen as a neutral glycolipid.
Cancer Immunol. Immunother. 41:348-354(1995)

PubMed=8873383; DOI=10.1007/BF00295899
Stadler W.M., Olopade O.I.
The 9p21 region in bladder cancer cell lines: large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genes.
Urol. Res. 24:239-244(1996)

Patent=US5622836
Walker K.Z., Russell P.J.
Monoclonal antibodies which recognize malignant cells from bladder carcinomas.
Patent number US5622836, 22-Apr-1997

PubMed=9246190; DOI=10.1080/09553009714349
Ribeiro J.C.C., Barnetson A.R., Fisher R.J., Mameghan H., Russell P.J.
Relationship between radiation response and p53 status in human bladder cancer cells.
Int. J. Radiat. Biol. 72:11-20(1997)

PubMed=23401075; DOI=10.1002/path.4176
Guo Y.-N., Chekaluk Y., Zhang J.-M., Du J.-Y., Gray N.S., Wu C.-L., Kwiatkowski D.J.
TSC1 involvement in bladder cancer: diverse effects and therapeutic implications.
J. Pathol. 230:17-27(2013)